Results 151 to 160 of about 72,644 (316)

Near-Infrared Intraoperative Imaging Can Successfully Identify Malignant Pleural Mesothelioma After Neoadjuvant Chemotherapy

Molecular Imaging, 2017
Malignant pleural mesothelioma is a deadly disease. Complete surgical resection provides patients with the best opportunity for long-term survival. Unfortunately, identification of disease during resection can be challenging.
Jarrod D. Predina MD, MTR, Andrew Newton MD, Greg Kennedy BA, M. Kenneth Lee MD, PhD, Sunil Singhal MD   +4 more
doaj   +1 more source

Malignant Mesothelioma Causing Bloody Pleural Effusion [PDF]

, 1982
Hong Bum Kim, Myeong‐Jin Kim, Soon Kew Park, Young Kee Shin   +3 more
openalex   +1 more source

Current chemotherapy strategies in malignant pleural mesothelioma.

Translational Lung Cancer Research, 2018
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with a 5-year survival rate of ~10%. Since most patients present with irresectable disease, the vast majority is treated with chemotherapy.
C. J. De Gooijer, P. Baas, J. Burgers
semanticscholar   +1 more source

Manganese Superoxide Dismutase in Healthy Human Pleural Mesothelium and in Malignant Pleural Mesothelioma [PDF]

, 1998
Katriina Kahlos, Sisko Anttila, Tiina M. Asikainen, K Kinnula, Kari O. Raivio, K. Mattson, Kaija Linnainmaa, Vuokko L. Kinnula   +7 more
openalex   +1 more source

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

The Journal of the National Comprehensive Cancer Network, 2016
These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Malignant Pleural Mesothelioma (MPM). These NCCN Guidelines Insights discuss systemic therapy regimens and surgical controversies for MPM.
D. Ettinger, D. Wood, W. Akerley, L. Bazhenova, H. Borghaei, D. Camidge, R. Cheney, L. Chirieac, T. D’amico, T. Dilling, M. Dobelbower, R. Govindan, M. Hennon, L. Horn, T. Jahan, R. Komaki, R. Lackner, M. Lanuti, R. Lilenbaum, Jules Lin, B. Loo, R. Martins, G. Otterson, J. Patel, K. Pisters, K. Reckamp, Gregory Riely, S. Schild, T. Shapiro, N. Sharma, S. Swanson, J. Stevenson, K. Tauer, Stephen C. Yang, K. Gregory, M. Hughes   +35 more
semanticscholar   +1 more source

Aquaporin 1, Aquaporin 3 and Aquaporin 5 expression and EGFR mutation in malignant pleural mesotheliomas: an imunohistochemical and molecular study

Biotechnology & Biotechnological Equipment, 2017
Malignant pleural mesothelioma is a rare and fatal malignancy. This disease is, unfortunately, at its advanced stage when it is diagnosed. Survival time is usually not more than a few months.
Ulaş Alabalık, Gül Türkcü, Ayşe Nur Keleş, İbrahim İbiloğlu, Zuhat Urakçı, Hüseyin Büyükbayram   +5 more
doaj   +1 more source

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group [PDF]

, 1996
Jan P. van Meerbeeck, Channa Debruyne, Nico van Zandwijk, PE Postmus, MC Pennucci, Frank van Breukelen, Danny Galdermans, Harry J.M. Groen, P. Pinson, M. van Glabbeke, Eric Van Marck, Giuseppe Giaccone   +11 more
openalex   +1 more source

Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma [PDF]

, 1995
Noriharu Shijubo, Yasuhiro Honda, Takuya Fujishima, Hiroki Takahashi, Taku Kodama, Yuichiro Kuroki, Tatsuaki Akino, Shinya Abe   +7 more
openalex   +1 more source

Differential CT Features between Malignant Mesothelioma and Pleural Metastasis from Lung Cancer or Extrathoracic Primary Tumor Mimicking Malignant Mesothelioma [PDF]

, 2000
Sung Il Lee, Young Hoon Ryu, Kwang Hun Lee, Kyu Ok Choe, Sang Jin Kim   +4 more
openalex   +1 more source

Malignant mesothelioma

Southwest Respiratory and Critical Care Chronicles, 2016
Seventy percent of patients with malignant mesothelioma have had exposure to asbestos fibers. Other patients without this exposure have had chronic pleural inflammation or received radiation to the thorax.
Suzanne Alkul, Hawa Edriss, Daniel Cordoba, Mitchell Wachtel   +3 more
doaj